mubritinib   Click here for help

GtoPdb Ligand ID: 6011

Synonyms: TAK 165 | TAK-165 | TAK165
Compound class: Synthetic organic
Comment: Mubritinib is a reversible inhibitor of EGFR and HER2. This compound is a Phase I clinical candidate.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 0
Rotatable bonds 11
Topological polar surface area 65.97
Molecular weight 468.18
XLogP 5.37
No. Lipinski's rules broken 2
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES FC(c1ccc(cc1)C=Cc1occ(n1)COc1ccc(cc1)CCCCn1nncc1)(F)F
Isomeric SMILES FC(c1ccc(cc1)/C=C/c1occ(n1)COc1ccc(cc1)CCCCn1nncc1)(F)F
InChI InChI=1S/C25H23F3N4O2/c26-25(27,28)21-9-4-20(5-10-21)8-13-24-30-22(18-34-24)17-33-23-11-6-19(7-12-23)3-1-2-15-32-16-14-29-31-32/h4-14,16,18H,1-3,15,17H2/b13-8+
InChI Key ZTFBIUXIQYRUNT-MDWZMJQESA-N
Classification Click here for help
Compound class Synthetic organic
IUPAC Name Click here for help
1-[4-[4-[[2-[(E)-2-[4-(trifluoromethyl)phenyl]ethenyl]-1,3-oxazol-4-yl]methoxy]phenyl]butyl]triazole
International Nonproprietary Names Click here for help
INN number INN
8446 mubritinib
Synonyms Click here for help
TAK 165 | TAK-165 | TAK165
Database Links Click here for help
CAS Registry No. 366017-09-6
ChEMBL Ligand CHEMBL1614707
GtoPdb PubChem SID 178102633
PubChem CID 6444692
Search Google for chemical match using the InChIKey ZTFBIUXIQYRUNT-MDWZMJQESA-N
Search Google for chemicals with the same backbone ZTFBIUXIQYRUNT
Search PubMed clinical trials mubritinib
Search PubMed titles mubritinib
Search PubMed titles/abstracts mubritinib
UniChem Compound Search for chemical match using the InChIKey ZTFBIUXIQYRUNT-MDWZMJQESA-N
UniChem Connectivity Search for chemical match using the InChIKey ZTFBIUXIQYRUNT-MDWZMJQESA-N
Wikipedia Mubritinib

Product suppliers

View disclaimer

Tocris
TAK 165 (links to external site)
Cat. No. 3599